These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 30366670

  • 21. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    Lin TY, Chen KC, Liu HJ, Liu AJ, Wang KL, Shih CM.
    PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340
    [Abstract] [Full Text] [Related]

  • 22. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L, Wang Y, Lin J.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [Abstract] [Full Text] [Related]

  • 23. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY, Yao M, Yang Z, Yang L, Liu XJ, Yu J, Ma Y, Zhang N, Zhang XY, Liu MH, Jiang LL, Luo JM.
    J Exp Clin Cancer Res; 2020 Jan 17; 39(1):17. PubMed ID: 31952546
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy.
    Li YL, Tang JM, Chen XY, Luo B, Liang GH, Qu Q, Lu ZY.
    Hum Cell; 2020 Jul 17; 33(3):610-618. PubMed ID: 32342278
    [Abstract] [Full Text] [Related]

  • 25. KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia.
    Zhang C, Shen L, Zhu Y, Xu R, Deng Z, Liu X, Ding Y, Wang C, Shi Y, Bei L, Wei D, Thorne RF, Zhang XD, Yu L, Chen S.
    Theranostics; 2021 Jul 17; 11(6):2691-2705. PubMed ID: 33456567
    [Abstract] [Full Text] [Related]

  • 26. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT, Günel NS, Ceyhan M, Çetintaş VB, Özel B, Yandım MK, Kıpçak S, Aktan Ç, Gökbulut AA, Baran Y, Can BK.
    Tumour Biol; 2015 Sep 17; 36(10):7915-27. PubMed ID: 25953263
    [Abstract] [Full Text] [Related]

  • 27. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang MD, Cai Q, Zhou D, Wang JD, Quan ZW.
    J Cell Mol Med; 2016 Dec 17; 20(12):2299-2308. PubMed ID: 27420766
    [Abstract] [Full Text] [Related]

  • 28. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D, Yang W, Zeng Y, Li W, Wang K, Zhao L, Li J, Ye Y, Guo Q.
    Cell Signal; 2021 Aug 17; 84():110038. PubMed ID: 33984486
    [Abstract] [Full Text] [Related]

  • 29. Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia.
    Liu Y, Li H, Zhao Y, Li D, Zhang Q, Fu J, Fan S.
    Bioengineered; 2022 Feb 17; 13(2):2296-2307. PubMed ID: 35034552
    [Abstract] [Full Text] [Related]

  • 30. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.
    Wang Q, Ding W, Ding Y, Ma J, Qian Z, Shao J, Li Y.
    Oncotarget; 2017 Jun 06; 8(23):37594-37604. PubMed ID: 28410239
    [Abstract] [Full Text] [Related]

  • 31. Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia.
    Kayabasi C, Okcanoglu TB, Yelken BO, Asik A, Susluer SY, Avci CB, Saydam G, Gunduz C.
    Gene; 2017 Dec 30; 637():173-180. PubMed ID: 28942039
    [Abstract] [Full Text] [Related]

  • 32. The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells.
    Zeng C, Liu S, Lu S, Yu X, Lai J, Wu Y, Chen S, Wang L, Yu Z, Luo G, Li Y.
    Mol Cancer; 2018 Aug 28; 17(1):130. PubMed ID: 30153828
    [Abstract] [Full Text] [Related]

  • 33. Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells.
    Yin Y, Sun H, Xu J, Xiao F, Wang H, Yang Y, Ren H, Wu CT, Gao C, Wang L.
    Leuk Lymphoma; 2015 Jun 28; 56(6):1813-20. PubMed ID: 25146433
    [Abstract] [Full Text] [Related]

  • 34. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
    Hekmatshoar Y, Ozkan T, Altinok Gunes B, Bozkurt S, Karadag A, Karabay AZ, Sunguroglu A.
    Cell Mol Biol (Noisy-le-grand); 2018 May 15; 64(6):23-30. PubMed ID: 29808796
    [Abstract] [Full Text] [Related]

  • 35. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L, Shan Y, Liu B, Li Y, Jia L.
    Cell Death Dis; 2017 May 25; 8(5):e2830. PubMed ID: 28542127
    [Abstract] [Full Text] [Related]

  • 36. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
    Hu N, Chen L, Wang C, Zhao H.
    Biomed Pharmacother; 2019 Apr 25; 112():108720. PubMed ID: 30970520
    [Abstract] [Full Text] [Related]

  • 37. circCRKL, a circRNA derived from CRKL, regulates BCR-ABL via sponging miR-877-5p to promote chronic myeloid leukemia cell proliferation.
    Wang J, Liang Y, Qin Y, Jiang G, Peng Y, Feng W.
    J Transl Med; 2022 Sep 04; 20(1):395. PubMed ID: 36058922
    [Abstract] [Full Text] [Related]

  • 38. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y, Li Y, Zhou Z, Ma M, Fu K.
    Biomed Pharmacother; 2017 Nov 04; 95():922-928. PubMed ID: 28915533
    [Abstract] [Full Text] [Related]

  • 39. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia.
    Lu Y, Li Y, Chai X, Kang Q, Zhao P, Xiong J, Wang J.
    Gene; 2017 Apr 05; 607():41-46. PubMed ID: 28069548
    [Abstract] [Full Text] [Related]

  • 40. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
    Li Z, Yang L, Liu X, Nie Z, Luo J.
    Biomed Pharmacother; 2018 Aug 05; 104():181-192. PubMed ID: 29772439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.